Olmesartan 20 mg + Hydrochlorothiazide 12.5 mg Tablets – OLBIX H 20/12.5

Olmesartan 20 mg + Hydrochlorothiazide 12.5 mg Tablets – Dual Action for Total Blood Pressure Control.

OLBIX H 20/12.5 – Olmesartan 20 mg + Hydrochlorothiazide 12.5 mg Tablets combines Olmesartan, an angiotensin receptor blocker (ARB), with Hydrochlorothiazide, a thiazide diuretic, to offer a dual-action approach to lowering blood pressure. Olmesartan works by blocking the angiotensin-II receptor, leading to the relaxation and dilation of blood vessels, which reduces elevated blood pressure and improves circulation. Hydrochlorothiazide inhibits sodium reabsorption in the distal convoluted tubule (DCT) of the kidneys, increasing the excretion of sodium and water. This reduction in blood volume helps lower cardiac output and further reduces blood pressure. This combination therapy provides an effective solution for managing hypertension, heart failure, and angina pectoris.

Recommended by Specialists:
✅General Physicians: For managing hypertension and resistant hypertension.
✅Cardiologists: For patients with cardiovascular events such as heart attacks and strokes.
✅Nephrologists: For protecting kidney function in hypertensive patients.

Key Benefits of Olmesartan 20 mg + Hydrochlorothiazide 12.5 mg Tablets – OLBIX H 20/12.5:

✅Synergistic Dual Action: The combination of vasodilator (Olmesartan) and diuretic (Hydrochlorothiazide) provides a comprehensive approach to managing cardiac issues, including hypertension, angina, heart failure, and stroke.
✅Dual Protection: Ensures cardioprotective and nephroprotective benefits, making it ideal for patients with CKD, diabetes, and resistant hypertension.
✅Well-Tolerated & Convenient: The once-daily dosing improves patient compliance and minimizes side effects due to the extended-release formulation.

Indications:
✅Hypertension
✅Resistant Hypertension
✅Hypertension with CKD
✅Hypertension with Diabetes
✅Cardiovascular Events (such as angina and stroke)